These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26307083)

  • 1. Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.
    Yuen M; Cooper ST; Marston SB; Nowak KJ; McNamara E; Mokbel N; Ilkovski B; Ravenscroft G; Rendu J; de Winter JM; Klinge L; Beggs AH; North KN; Ottenheijm CA; Clarke NF
    Hum Mol Genet; 2015 Nov; 24(22):6278-92. PubMed ID: 26307083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a R133W beta-tropomyosin mutation on regulation of muscle contraction in single human muscle fibres.
    Ochala J; Li M; Tajsharghi H; Kimber E; Tulinius M; Oldfors A; Larsson L
    J Physiol; 2007 Jun; 581(Pt 3):1283-92. PubMed ID: 17430991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy.
    Ottenheijm CA; Lawlor MW; Stienen GJ; Granzier H; Beggs AH
    Hum Mol Genet; 2011 May; 20(10):2015-25. PubMed ID: 21357678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy.
    Ilkovski B; Mokbel N; Lewis RA; Walker K; Nowak KJ; Domazetovska A; Laing NG; Fowler VM; North KN; Cooper ST
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):867-77. PubMed ID: 18716557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.
    Borovikov YS; Karpicheva OE; Simonyan AO; Avrova SV; Rogozovets EA; Sirenko VV; Redwood CS
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding.
    Moraczewska J; Robaszkiewicz K; Śliwinska M; Czajkowska M; Ly T; Kostyukova A; Wen H; Zheng W
    FEBS J; 2019 May; 286(10):1877-1893. PubMed ID: 30768849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropomyosin in the groove? Molecular insights into an inherited myopathy.
    Chase PB
    J Physiol; 2007 Jun; 581(Pt 3):889. PubMed ID: 17525111
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3.
    Waddell LB; Kreissl M; Kornberg A; Kennedy P; McLean C; Labarre-Vila A; Monnier N; North KN; Clarke NF
    Neuromuscul Disord; 2010 Jul; 20(7):464-6. PubMed ID: 20554445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.
    Donkervoort S; Papadaki M; de Winter JM; Neu MB; Kirschner J; Bolduc V; Yang ML; Gibbons MA; Hu Y; Dastgir J; Leach ME; Rutkowski A; Foley AR; Krüger M; Wartchow EP; McNamara E; Ong R; Nowak KJ; Laing NG; Clarke NF; Ottenheijm C; Marston SB; Bönnemann CG
    Ann Neurol; 2015 Dec; 78(6):982-994. PubMed ID: 26418456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7.
    Borovikov YS; Andreeva DD; Avrova SV; Sirenko VV; Simonyan AO; Redwood CS; Karpicheva OE
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.
    Karpicheva OE; Avrova SV; Bogdanov AL; Sirenko VV; Redwood CS; Borovikov YS
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanisms of a high Ca
    Avrova SV; Karpicheva OE; Simonyan AO; Sirenko VV; Redwood CS; Borovikov YS
    Biochem Biophys Res Commun; 2019 Jul; 515(2):372-377. PubMed ID: 31155291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca
    Borovikov YS; Simonyan AO; Avrova SV; Sirenko VV; Redwood CS; Karpicheva OE
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Variant in
    Robaszkiewicz K; Siatkowska M; Wadman RI; Kamsteeg EJ; Chen Z; Merve A; Parton M; Bugiardini E; de Bie C; Moraczewska J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle.
    Karpicheva OE; Simonyan AO; Kuleva NV; Redwood CS; Borovikov YS
    Biochim Biophys Acta; 2016 Mar; 1864(3):260-267. PubMed ID: 26708479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of congenital myopathy-related mutations in gamma-tropomyosin gene.
    Robaszkiewicz K; Dudek E; Kasprzak AA; Moraczewska J
    Biochim Biophys Acta; 2012 Oct; 1822(10):1562-9. PubMed ID: 22749829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
    Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
    Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.
    Moraczewska J; Greenfield NJ; Liu Y; Hitchcock-DeGregori SE
    Biophys J; 2000 Dec; 79(6):3217-25. PubMed ID: 11106625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.
    Akkari PA; Song Y; Hitchcock-DeGregori S; Blechynden L; Laing N
    Biochem Biophys Res Commun; 2002 Aug; 296(2):300-4. PubMed ID: 12163017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel TPM3 mutation in a family with cap myopathy and review of the literature.
    Schreckenbach T; Schröder JM; Voit T; Abicht A; Neuen-Jacob E; Roos A; Bulst S; Kuhl C; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2014 Feb; 24(2):117-24. PubMed ID: 24239060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.